[DOI] [PMC free article] [PubMed] [Google Scholar] 25.Passantino A., Quartarone V., Pediliggeri M.C., Rizzo M., Piccione G
Opening Remarks Bridging the Gap: A Role-Playing Exercise in Marketing, Legal and Compliance Alignment Marketing wants to move fast
Geographic variation of amyotrophic lateral sclerosis incidence in New Jersey, 20092011
Sin embargo, en Espaa, la semaglutida solo est aprobado hasta el momento para el tratamiento de la diabetes tipo II bajo el nombre comercial de Ozempic
Statements Author contributions Both authors EM and SB have participated equally in article conception and design, acquisition of data, analysis and interpretation of data, drafting of manuscript, critical revision, and final approval of the version to be published
Understanding the Long-Term Plan Semaglutide is not a quick fix but part of a long-term strategy for weight loss and maintenance